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Genetic suppressor elements (GSEs) are short biologically active gene fragments 
that encode inhibitory antisense RNAs or truncated proteins that function as negative 
dominants. GSEs can be constructed from a single gene or isolated from a multigene 
library consisting of short random fragments of the target gene or genes. 
The goal of this study was to determine if gene inhibition in bacterial cells could be 
achieved by isolating GSEs from a genomic library. Additionally, if it was possible to use 
GSEs to inhibit gene function in E. coli JM109DE3 cells, could this method be used to 
locate and determine the function of unknown genes? In this study, antisense GSEs were 
isolated clearly showing that it was possible to inhibit function of known and unknown 
genes in bacterial cells using genetic suppressor elements derived from a genomic library. 
VI 
Introduction 
Characterization of gene expression is an ongoing endeavor. To understand the 
function of a particular gene, one can manipulate or mutate a gene such that it will alter 
or inhibit the gene's expression and may lead to a specific phenotypic effect on the 
organism. Classical mutation studies, although they reveal useful information, occur 
randomly and this randomness makes it difficult to study individual genes 
systematically (1). 
The classic mutational approach to gene function involves use of chemicals or 
radiation to alter genes at random. Cells and their progeny displaying altered 
characteristics are isolated and then studied. This approach has been very successful with 
microorganisms; however, it does not allow one to know the functional chromosomal 
location of the mutated genes and does not insure that only one gene has been mutated. 
For example, if a mutation inhibits a microorganism's ability to grow in the presence of a 
particular sugar, it is not known whether this mutation is blocking one of the 
microorganism's abilities to catabolize the sugar and/or inhibiting the cell's uptake of the 
sugar. A large accumulation and classification of mutants is needed for understanding of 
the complex biochemistry involved. 
An alternative approach would be to use reverse genetics. Here, genes of interest are 
inserted into a vector, which is then transformed into a cell or organism. The cloned gene 
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is deliberately mutated and the phenotype observed to understand its function. One such 
strategy is the production of genetic suppressor elements (GSEs). 
Genetic Suppressor Elements 
GSEs are short biologically active gene fragments that encode inhibitory antisense 
RNAs or truncated proteins that dominantly inhibit the function of native protein subunits 
(dominate negative mutants). These GSEs can be constructed from a single gene or 
isolated from a multigene library consisting of short random fragments of the target gene 
or genes cloned into an expression vector. Genetic information flows from DNA to 
mRNA, which in turn is translated into a functional protein. Antisense RNAs bind to 
mRNAs that are complementary in sequence and inhibit the genetic information flow at 
the level of translation. Dominate negative mutants block the function of normal proteins 
by associating with the wild-type monomer and rendering this monomer nonfunctional 
(Figure I). Holzmayer and colleagues first noted GSEs in a study where GSEs were 
produced by random fragmentation of the lambda DNA. This fragmentation inhibited the 
functioning of specific genes involved in lambda-induced lysis of E. coli K12 cells (2). 
Holzmayer's study described for the first time that a dominant, negative mutant GSE 
designated Ea8.5 protected E. coli K12 from lambda-induced lysis. 
In 1993, GSEs were generated from randomly fragmented human topoisomerase II 
(Topo II) cDNA in order to isolate clones conferring resistance to etoposide. GSEs 
encoding antisense RNA decreased cellular expression of the Topo II a-protein. Sense 
and antisense GSE's isolated in this study were found to induce resistance to several 
Topo II poisons. 
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Figure 1. The Principles of Antisense RNA and Truncated Protein Inhibition. 
1. The genetic information flows from DNA to mRNA, and then is translated into a 
functional protein. 2. The function of the normal protein can be blocked by association 
with the truncated protein. 3. The genetic information flow can also be blocked at the 
translation level if an antisense gene, which has a sequence complementary to the 
mRNA, is introduced into the cell. 
Xinnan Nin, 1999, Inactivation of Glutamme Synthetase (glnA) and Putative Sulfate 
transport (cysZ) Genes in E. coli by Antisense and Truncated Gene Strategies. Western 
Kentucky University, Bowling Green, Kentucky Thesis 
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Peptide-coding GSEs indicated structural domains of Topo II capable of independent 
functional interaction. Two such areas include a N-terminal putative ATP-binding site 
and the section between the active site and a leucine zipper region, which may be 
involved in protein dimerization (3). Use of GSEs also demonstrated that it was an 
efficient approach for selecting mammalian cells whose downregulation of kenesin 
resulted in a selectable phenotype (4). 
Genetic suppressor elements are useful in molecular oncology (5) and an effective 
functional indicator of the multidrug transporter P-glycoprotein (6). It is clear that GSEs 
are efficient tools that can illuminate the role of genes in both prokaryotic and eukaryotic 
cells. 
Dominant, Negative Mutants and Antisense RNA 
An overview of the two types of genetic suppressor elements, antisense RNA and 
dominant negative mutants, is essential in understanding the logic behind the use of 
GSEs. Cloning of randomly fragmented DNA into a vector capable of transcription of 
those fragments potentially produces two types of genetic suppressor elements. One such 
type is a dominant, negative mutant and is expressed as a truncated form of a naturally 
occurring protein (2). The truncated protein has the ability to interfere with the function 
of the wild-type protein subunit activity in a dominant manner (3) by rendering one or 
more functional domains inactive (Figure 1) (6). Truncated proteins that serve as 
dominant negative mutants are most effective at inhibiting multimeric proteins (7). 
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The other type of GSE generated during cloning of randomly fragmented DNA into an 
expression vector is antisense RNA. These transcribed GSEs base pair with target mRNA 
to inhibit protein synthesis (Figure 1). Antisense RNAs bound to mRNA may shield the 
site from ribosome binding and thus prevent initiation of protein synthesis. Duplexed 
antisense RNAs may also serve as a target for endonucelases, and therefore increase the 
rate of mRNA turnover (1). 
Dominant Negative Mutations Occurring in Nature 
Since the initial suggestion by Herskowitz (8) that dominant negative mutations could 
be used as a tool to study the functions of specific genes, it has become evident that these 
mutations also occur naturally. In fact, a number of examples for this type of inhibitory 
interaction in nature have been described. 
One such example is the syndrome of thyroid hormone resistance in humans. Thyroid 
hormone syndrome is an autosomal dominant disorder identified by high levels of 
circulating thyroid hormone and organ resistance to the hormone (9). This disease is 
caused by mutations in the £> form of the thyroid hormone receptor TR/3 , a nuclear 
receptor that exerts its normal action by interacting with specific hormone-responsive 
genes. The dominant negative effect of these mutations is due to their ability to form 
nonfunctional heterodimers with wild-type TR/3, leading to the activation or repression 
of target gene (9). 
Another DNA binding protein that exerts a dominant negative effect is p53. Mutant 
forms of p53 are common in several types of human cancer. Naturally occurring p53 
mutants have been shown to inhibit the function of wild-type p53 by forming 
heterodimers with wild-type p53. This effect appears to involve sequestration of these 
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heterodimers in the cytoplasm, preventing the translocation of wild-type p53 into the 
nucleus (10). 
Dominant, negative mutations in the cytoplasmic tyrosine kinase domain of insulin 
receptors have been identified in insulin resistant patients. The dominant negative effect 
is exerted when the mutant receptor competes with wild-type receptors and interferes 
with the initiation of the signaling cascade during receptor dimerization (11). 
Mechanisms of Dominant Negative Mutants 
Variants of wild-type proteins that are overproduced have the ability to inhibit protein 
function. These variants can be designed, because their proteins have multiple functional 
sites that can be mutated independently (8). Some examples of the functional sites that 
can be targeted for mutation are oligomerization sites, substrate-binding sites and 
catalysis sites. Proteins mutated within a functional site are capable of interacting with 
their wild-type protein counterparts and interfere with the normal function of the wild-
type and thus function as a dominant negative mutant. If a multimeric enzyme's active 
sites or regulatory sites are known or can be inferred, then it is possible to make specific 
mutations that may generate dominant negative mutants. These specific mutations can be 
useful in identification of active domains in a protein. 
Gene-regulatory proteins such as the lac or trp repressors bind to DNA as dimers to 
regulate their respective target operons. Removing the carboxy-terminal end responsible 
for DNA binding (12) can produce a dominant negative version of the trp repressor. 
DNA-binding proteins utilize sequence motifs such as the 'helix-turn-helix' (13,14) as 
their DNA-binding domain. Removal of part or the entire motif sequence can produce a 
dominant negative mutant. 
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Another mode of inhibition by DNA-binding proteins turns transcription activators 
into repressors (8). An example of this mode of inhibition is the x gene of the human T-
cell leukemia virus HTLV-II. Mutations in the HTLV-I1 transcription activator have been 
shown to block the wild-type protein's activation of transcription (15). 
Studies of hybrids formed between E. coli aspartate transcarbamylase wild-type and 
mutant subunits illustrate two separate ways that mixed aggregates can inhibit enzyme 
function (8). First, mutants modified within the active-site residues can associate with 
wild-type subunits to form nonfunctional aggregates (16) because the active site of the 
enzyme is composed of residues from adjacent subunits (17). Second, subunits with 
modifications outside the active site can inhibit enzyme function when mixed aggregates 
fail to respond to the binding of a ligand because the protein is in an inactive 
conformation (18). Enzymes with multiple subunits and catalytic sites at subunit 
interfaces such as the glutamine synthetase (12 subunits) would be very sensitive to 
aggregation with mutant subunits (19). 
Prokaryotic and Eukaryotic Antisense RNAs in Nature 
Many antisense RNAs occur in nature, and act as regulational elements in both 
prokaryotic and eukaryotic systems. The first prokaryotic antisense RNA inhibitor 
identified was the micF RNA in E. coli. The micF RNA is complementary to the Shine-
Dai garno site and the initiation codon of the ompF mRNA (20,21). The micF inhibition 
of the ompF gene is induced by high temperature, the presence of salicylate, and 
mutations at the mar A or tolC loci (22). 
The antisense RNA dicF is part of an operon that has six open reading frames and 
inhibits the ftsZ gene that codes for a protein involved in an early step of cell division in 
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E. coli. FtsZ is a membrane-associated protein that binds and hydrolyzes GTP. DicF 
RNA inhibits ftsZ gene expression at the post-transcriptional level when its RNA binds to 
ftsZ mRNA at the Shine-Dalgarno ribosomal binding site and AUG translational start 
sequences (23). 
The DNA region coding for glutamine synthetase in C. acetobutylicum contains an 
antisense promoter (P3) located downstream from the sense promoters Pi and P2 The P3 
promoter controls the transcription of an antisense RNA, complementary to a 43-base 
region encompassing the ribosomal binding site and the initiation codon at the 5' end of 
the glnA mRNA (24). 
Another example of natural antisense regulation involves inhibition of replication in 
the plasmid pT181. Two antisense RNAs (RNA I, RNA II) which are complementary to 
the RepC mRNA leader sequence induce premature termination of transcription by 
altering mRNA secondary structure conformation. The RepC protein whose RNA is 
transcribed from two different promoters producing RNA III and RNA IV. RNA 1 and 
RNA II differ at their 3' ends which are complementary to the 5' untranslated regions of 
the mRNA coded by RNA III and RNA IV (25). 
Some mobile genetic elements have been found to use antisense inhibition as a control 
mechanism. Tn/0 is a composite transposon that encodes a transposase, tnp, located in 
each terminal IS 10. A promoter, RNA-OUT, is adjacent to and oriented in the opposite 
direction to the tnp promoter, RNA-IN, and produces an overlapping complementary 
transcript that blocks the ribosomal binding site of the tnp mRNA. Blocking the tnp 
ribosomal binding site inhibits transposase production and therefore limits the mobility of 
these genetic elements (26, 27). 
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Bacteriophages have also been found to use naturally occurring antisense RNAs to 
regulate lysogeny. The temperate bacteriophages PI and P7 produce antisense RNA that 
inhibits antirepressor (Ant) synthesis which is essential for establishment and 
maintenance of lysogeny (28). Other temperate bacteriophages such as P22 and Lambda 
use antisense RNA to inhibit gene expression. P22 uses antisense'RNA to inhibit the 
expression of the ell gene where as Lambda uses antisense RNA to inhibit the expression 
of the cro gene. Both the ell and cro genes promote the lytic cycle (29). 
Antisense RNA has been found to regulate HIV-1 gene expression of the env gene. 
Sequences in the rev-response element overlap the env gene and arrest translation of the 
HIV-1 envelope (30,31,32,33, and 34). The predominance of eukaryotic gene loci, 
which transcribe both sense and antisense RNA species have only recently been 
acknowledged. The high frequency of in-phase open reading frames in the antisense 
strands of recognized eukaryotic gene sequences suggests that the number of reported 
natural antisense RNAs will continue to grow (35). One known example includes 
regulation of transcriptional elongation in the N-/wyc gene by the N-cym antisense RNA 
(36). Also, translational control of the myosin heavy chain is regulated by two isoforms 
of the tcRNA102 (A and B) from chicken muscle which show a significant amount of 
homology to the 5' end of the myosin heavy chain mRNA (37). 
Mechanisms and Applications of Artificial Antisense RNA 
In 1963, Singer and others demonstrated that inhibition of translation was due to an 
antisense element (39,38). Singer and his colleagues showed that phenylalanine 
synthesis was completely blocked if polyadenylic acids were present in a cell-free 
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translation reaction system (39). Other reports also confirmed that many RNAs 
complementary to cellular RNA blocked translation. (40). 
In 1977, Patterson et al. developed a method termed hybrid-arrested-translation or 
H. A.R.T which demonstrated that the translation of /3-globin mRNA was reversibly 
inhibited when it was hybridized with denatured DNA from a recombinant plasmid, 
P/3G1, which carried the 9S rabbit globin gene. (41). Using the H. A.R.T. method allowed 
Patterson and his colleagues to map structural and regulatory sequences in adenovirus 2 
(41). A few months later, Hastie and his colleagues looked at mRNA populations (42) 
through hybridization of mRNA to their corresponding cDNA which specifically 
inhibited the translation of the mRNA in vitro (42). Equivalent amounts of globin cDNA 
and mRNA were required to inhibit globin synthesis completely. Also, it was found that 
the rate of inactivation was identical to the rate of hybridization between globin cDNA 
and globin mRNA (42). 
The hybrid-arrested-translation method involved DNA-RNA hybridization after 
double- stranded DNA was denatured through heating and then annealed to mRNA. This 
strategy blocked translation of the mRNA, however, both the Patterson and Hastie studies 
were conducted within cell free systems. Still to be resolved was the problem of how to 
achieve this effect in intact cells. 
In 1984, a method for inhibiting mRNA in intact cells was developed (43). Pestka and 
colleagues constructed a plasmid that could generate mRNA that was complementary to 
/3-galactosidase mRNA. In this study, /3-Galactosidase protein production was inhibited 
by 98%, the galactoside permease by 80% and the transacetylase by 55% (43). These 
studies began the application of antisense technology. 
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The mechanisms of antisense RNA inhibition have been divided into three classes 
based on the location of antisense RNA binding on the mRNA. Class I antisense RNAs 
are directly complementary to the Shine-Dalgarno sequence and/or coding regions of the 
target mRNA (44). Most antisense RNAs belong to Class I. Class I RNAs are divided 
into two subclasses. One of the subclasses contains antisense RNA that binds directly to 
the Shine-Dalgarno sequence and/or the coding region on target mRNA and inhibits 
translation. The other, Class IB antisense RNA, destabilizes the target mRNA and renders 
it susceptible to nucleases (44). 
Class II antisense RNAs bind to a region upstream from the Shine-Dalgarno sequence. 
This class of antisense RNA exerts a secondary effect by binding to regions far from their 
functional targets. Such regulation by class II RNAs is considered to be due to refolding 
of an RNA molecule and as a result of a hybrid formation occurring at a region far from 
the target site. Class II antisense RNAs are the most difficult to design. The difficulty 
arises because Class II-type antisense RNA regulation has a limited availability of the 
target mRNA and the complicated requirement of RNA folding (44). 
Class III antisense RNA function at the transcriptional level by mimicking the Rho-
factor-independent transcription termination signal. The antisense RNA hybridizes to the 
mRNA upstream from a stretch of Us, forming a double-stranded RNA region that is 
recognized by the RNA polymerase as a transcriptional termination signal which causes 
premature transcription termination (45). 
Artificially designed antisense RNAs have been used to inhibit gene function for a 
number of different applications such as plants (46,47,48,49, 50), pharmaceutical 
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agents (51,52), microorganisms used in the environment (53), gene therapy for hepatitis 
B viral infection (54) and pathogenic genes carried by bacteria (55). 
Experimental Approach 
The genome of E. coli K12 was entirely sequenced in 1997 and of the 4,288 protein 
coding regions identified, 38 % were found to have no known function (56). Sequencing 
of the entire genome of E. coli K12 provided an excellent opportunity to explore the 
power of genetic suppressor elements (GSEs) in mapping cell functions to specific genes. 
The objectives of this study were to: 1. Determine if GSEs would inhibit gene functions 
related to growth of E. coli on minimal media, 2. Identify the gene that was related to the 
GSE, and 3. To determine if any of the isolated genes had an unknown function assigned 
to them, thus, justifying further investigation. 
The experimental approach was patterned after Holzmayer et al. (2), which was 
effective in identifying a previously unknown gene in the lambda phage. In this study, 
E. coli JM109 DE3 DNA was randomly fragmented, size selected, and cloned into a 
plasmid vector, such that the fragments could be inserted in either the coding or antisense 
orientation relative to the T7 RNA polymerase promoter. The recombinant vectors were 
then transformed back into the E. coli JM109 DE3 cells to form a library of plasmids 
carrying genomic DNA. The E. coli JM109 DE3 strain was chosen as a host because it 
carried a T7 RNA polymerase gene downstream of an IPTG inducible lactose promoter 
and allowed transcription of the GSE from the vector's T7 RNA polymerase promoter 
whenever IPTG was present and T7 RNA polymerase expressed. E. coli JM109 DE3 
cells transformed with clones from the genomic library were plated on rich media and 
then replica plated onto minimal media containing IPTG and without IPTG. Colonies that 
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grew on the plates without IPTG but grew either slowly or not at all on the plates with 
IPTG were said to carry a GSE. 
GSE containing plasmids were further analyzed for GSE length by digestion with 
restriction enzymes. The nucleotide sequence of the GSE was also determined, and the 
sequence was matched to a location on the E. coli genome. Any known or putative 
functions for the identified GSE were noted. Finally the GSE was identified as being in 
either the sense or antisense orientation relative to plasmid T7 promoter, and the various 
mechanisms of inhibition were explored for each clone. 
Methods and Materials 
Vector Construction 
The vector used in this study was a hybrid plasmid, pAV, constructed by Todd 
Holland at Western Kentucky University from fragments of the plasmids pGEMEX™2 
and pGEMR-3 (Promega, Madison WI.) (Figure 2). The first section of pAV consists of 
the small Sea I to Hind III fragment from pGEMX™2 and harbors part of the ampicillin 
resistance gene, the fl origin of replication, a T7 transcription terminator and the Sp6 
RNA polymerase promoter. The large Sea I to Hind III fragment from the pGEMR-3 
plasmid includes the end of the multiple cloning site, the T7 RNA polymerase promoter, 
a ColEl origin of replication and two thirds of the ampicillin resistance gene. 
Growth and Isolation of Plasmids 
Isolation of the plasmid vector was done according to the large, scale plasmid prep 
protocol found in Protocols and Applications Guide (57). 
Phenol Extraction and Ethanol Precipitation 
To remove protein from the plasmid, 1 volume of TE (10 mM Tris-HCl pH 8.0, ImM 
EDTA pH 8.0) saturated phenol/chloroform/ isoamyl alcohol (25:24:1) (58) was added to 
the lysate and shaken to extract the plasmid before being centrifuged at 12,000 x g for 15 
minutes. The white precipitate at the interface of the phases was carefully avoided and 
the aqueous phase was transferred to a sterile tube. 
- 1 4 -
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Figure 2. Construction of pAV Vector: The gray outlined Sea I / Hind III segments 
from pGEM-3 & pGEMEX-2 were ligated together to produce the pAV vector. 
Xinnan Nin, 1999, Inactivation of Glutamine Synthetase (glnA) and Putative Sulfate 
transport (cysZ) Genes in E. coli by Antisense and Truncated Gene Strategies. Western 
Kentucky University, Bowling Green, Kentucky Thesis 
Two volumes of ice cold 95 % (v/v) ethanol were added to the aqueous phase which was 
incubated at -80°C for 30 minutes and then centrifuged at 12,000 x g for 15 minutes to 
pellet the plasmid DNA. This pellet was washed with 2-3 mL of ice cold 70 % (vol/vol) 
ethanol and re-centrifuged at 12,000 x g for 10 minutes. Following the centrifugation, the 
DNA pellet was dried under vacuum for 10 minutes and then resuspended in 500 jjL of 
nuclease free water. RNase One (5 units for 1 hour at 37°C) (Promega) was used to 
remove any residual RNA, and the plasmid was purified a final time using the phenol 
extraction/ethanol precipitation procedure just described. 
Agarose Gel Electrophoresis 
Agarose gels were prepared according to Maniatis et al (59), except that 2.5 /LiL of 
lOmg/mL ethidium bromide was added to each 50 mL agarose gel. Gels were 
electrophoresed at 100 volts for about 1-1.5 hours in a IX TBE buffer (0.089 M Tris, 
0.089 M Boric acid, 2.0 mM EDTA, pH 8.0). The DNA was visualized under UV light 
using the Kodak Digital Science image analysis system. 
Linearization and Dephosphorylation of pAV 
Linearization and dephosphorylation of plasmid DNA were carried out according to 
the protocol found in Protocols and Applications Guide from Promega (60). The plasmid 
linearization consisted of digesting the plasmid vector with BamH I restriction enzyme at 
0.5 units/jjg DNA and IX BamH I restriction enzyme buffer (New England Biol abs) 
then incubated at 37°C overnight. Linearization was confirmed by agarose gel 
electrophoresis. 
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Linear plasmid was dephosphorylated using shrimp alkaline phosphtase (USB) 
O.Olunits/pmol DNA end, and IX shrimp alkaline phosphotase buffer and incubated at 
37°C for 90 min. The shrimp alkaline phosphotase was inactivated by heating the 
reaction mixture in a hot water bath at 65°C for 15 minutes. The reaction mixture was 
then extracted once with an equal volume of phenol and ethanol precipitated as described 
above. 
Isolation and Purification of Genomic DNA 
Isolation of genomic DNA was carried out using the procedure found in Current 
Protocols (61). A single colony of JM109 DE3 cells (Promega, Madison, WI) was used 
to inoculate 2 mL of LB broth (1% w/v bacto-tryptone, 0.5 % w/v bacto-yeast extract, 1% 
w/v NaCl) and grown overnight at 37°C with shaking at 250 rpm. An aliquot of 1.5 mL 
of this overnight culture was used to inoculate 500 mL of LB/broth and grown overnight 
at 37°C with shaking at 250 rpm. The 500mL cell culture was centrifuged at 10,000 X g 
for 10 minutes to pellet the cells. The supernatant was discarded, and the cells were 
resuspended with 47.5 mL of lx TE. Next, 2.5 mL 0.5 % SDS (w/v) and 250 fjL of 
proteinase K (20mg/mL) were added and mixed thoroughly. The suspension was 
incubated at 37°C for 1 hour. After incubation, 9 mL of 5 M NaCl was added and 
thoroughly mixed. Seven and one half milliliters of 1% (w/v) hexadecyltrimethyl 
ammonium bromide (CTAB) solution and 80 mL nuclease free water was added, mixed 
and incubated at 65°C for 20 minutes. 
An equal volume of chloroform/isoamyl alcohol (24:1) was added to the cell lysate 
and centrifuged at 6,000 x g for 10 minutes. The upper aqueous phase was transferred to 
a sterile tube, and 0.6 volumes of isopropanol were added to precipitate the 
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DNA. The precipitated genomic DNA was removed using a bent glass rod and 
transferred to a sterile, centrifuge tube containing 5 mL 70 % (v/v) ethanol. The DNA 
was centrifuged at 10,000 x g for 5 minutes; the genomic DNA pellet was vacuum dried 
for 10 minutes, the pellet was resuspended with 4 mL of TE and transferred to a sterile 
culture tube. The concentration of genomic DNA was adjusted to 100 yg/ mL with TE; 
then to 8 mL of solution, 8.6 g of cesium chloride along with 400 L of lOmg/mL 
ethidium bromide were added and transferred to ultracentrifuge tubes. The density of the 
CsCl/ETBr solution was 1.55 g/mL. The tubes were centrifuged in an ultracentrifuge at 
145,000 x g at 15°C for 24 hours. The gradient was then visualized under an UV lamp, 
and the genomic DNA band was removed and placed in a sterile tube. Ethidium bromide 
was removed by sequential extractions with water-saturated butanol until the ethidium 
bromide was visibly removed. The DNA was dialyzed overnight against 2 liters of TE. 
The DNA solution was transferred to a fresh tube and precipitated by adding 1/10 volume 
of 3 M sodium acetate and 0.6-volume isopropanol. Precipitated genomic DNA was 
centrifuged at 10,000 x g for 10 minutes and the pellet resuspended in nuclease free 
water. 
Partial Digestion of Genomic DNA 
Partial digestion of genomic DNA was based on the procedure found in Applications 
and Protocols (62). The 400 )jL of digestion reaction mix contained 175 IJg genomic 
DNA, 40 jjL lOx Sau3A I restriction enzyme buffer and 50 units Sau3A I restriction 
enzyme (New England Biological). The reaction was incubated at 37°C and a 10 /JL 
aliquot was removed each hour for electrophoresis to determine digestion status. 
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Isolation of Genomic DNA Fragments 
Size fractionation of the genomic DNA was accomplished by passing the fragments 
over a Sepharose CL-4B column (63). Ten milliliters of pre-swollen Sepharose CL-4B 
(Sigma) and 35 mL CL-4B column buffer (.01 M Tris-Cl, pH 8.0, 0.6 M NaCl, 
0.001 M EDTA, pH 8.0, 0.5 % w/v Sarkosyl) was added to a 50 mL centrifuge tube then 
mixed and allowed to settle by gravity for 10 minutes. The column buffer was aspirated 
to remove any unsettled fines. This process was repeated two additional times. Fresh CL-
4B column buffer (lOmL) was added, mixed by inversion several times and incubated at 
37°C for 10 minutes to avoid outgassing during column assembly. A 5 mL plastic pipet 
was used as the column with silanized glass wool placed into the tip of the pipet to act as 
a filter. The Sepharose was added to the column to a total volume of 5 mL, and the 
column was washed with 15 mL of CL-4B column buffer to ensure even packing of the 
Sepharose and to establish a constant flow rate of 1 mL/minute. The fragmented genomic 
DNA (280 jjL) was added to the column and fractions of 5 drops (170 jjL) were 
collected. A 10 /jL aliquot of each fraction was electrophoresed on an agarose gel 
electrophoresis to determine which fractions harbored the desired fragment range. Those 
fractions with the desired fragment sizes were pooled and purified by the phenol 
extraction/ethanol precipitation method described above. 
Ligation of DE3 fragments to the pAV Vector 
Ligation of the genomic DNA fragments to the linear, dephosphorylated plasmid was 
done according to the protocol found in Protocols and Application Guide (64). Reactions 
were setup in a total volume of 10 jjL containing 1/jg of dephosphorylated pAV and 
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363 ng of genomic DNA fragments, 20 units T4 DNA ligase (New England Biological), 
and 1.0 fiL of lOx T4 DNA ligation buffer (66 mM Tris-HCl, pH 7.6, 6.6 mM MgCl2, 
LOMM DTT, 66 pM ATP). Reactions were incubated at 16°C overnight. A 3 /JL aliquot 
from each reaction was electrophoresed on an agarose gel to determine the ligation status. 
Transformation by High-Efficiency Electroporation 
Transformation of the recombinant plasmid vector into bacterial cells followed the 
procedure found in Current Protocols (65). A single colony of E. coli JM109 DE3 was 
inoculated into 5 mL LB broth and grown overnight at 37°C with shaking at 250 rpm. A 
2.5 mL aliquot of this overnight culture was used to inoculate 500 mL of LB broth and 
grown at 37°C with shaking (250 rpm) to an OD 0.6. The cells were chilled in an ice bath 
for 10-15 min and then centrifuged at 3000 x g for 20 minutes at 4°C to pellet the cells. 
The supernatant was discarded and the pellet completely resuspended with 5 mL sterile 
nuclease-free water. To render the bacterial cells electrocompetent, the cells were wash 2 
times using 500 mL of chilled, sterile, nuclease-free water. The cells were centrifuged at 
3000 x g for 10 minutes at 4°C. The final cell pellet was resuspended with 5 mL of 
chilled sterile water and transferred to a sterile, pre-chilled tube and then centrifuged at 
3000 x g for 10 min at 4°C. The pellet volume was estimated visually and the cells were 
resuspended in an equal volume of chilled, sterile, nuclease-free water. The cell 
suspension was transferred in 100 /jL aliquots to sterile pre-chilled 1.5 microcentrifuge 
tubes and kept on ice. 
The electroporation apparatus was set at 1260 volts and 400 ohms. Recombinant 
plasmid 0.5 ng was added to 100 (jL electrocompetent cells. The entire mix was 
transferred to a sterile pre-chilled electroporation cuvette with a 1mm gap and placed on 
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ice for 5 minutes. The cuvette was then placed into the sample chamber of the 
electroporation apparatus and the current was applied. The cells were then transferred to 
1 mL SOC medium (0.5 % w/v yeast extract, 2 % w/v tryptone, lOmM KC1, lOmM 
MgCl2, lOmM MgS04, 20mM glucose) and incubated for 60 min at 37°C with moderate 
shaking at 250 rpm. Aliquots of the transformed cells were plated onto LB plus 
ampicillin (50 mg/mL) agar plates to determine transformation efficiency and titer. 
Amplification and Titer of the Genomic DNA Library 
Protocol for amplification of the genomic DNA library was found in Current 
Protocols (66). The library of recombinant cells was amplified by diluting 900 /jL of 
transformed cells with 35 mL of LB broth plus ampicillin (50 /Jg/mL) and grown 
overnight at 37°C with shaking at 250 rpm. The amplified library was prepared for 
storage by adding 6.75 mL of sterile 100 % v/v glycerol and 3.25 mL sterile nuclease-
free water, raising the total volume to 45 mL. The amplified library was transferred to 
sterile microcentrifuge tubes in 1 mL aliquots per tube and stored at -80°C for future use. 
To obtain the titer, a 100 JJL aliquot of the amplified library was serially diluted from 
10"1 to 10"10 with sterile, nuclease-free water. Aliquots of 100 ijL from each dilution were 
plated onto LB plus ampicillin (50 yg/mL) agar plates. The titer plates were grown 
overnight at 37°C. The titer was determined using the protocol found in Current 
Protocols (66). 
Screening the Genomic DNA Library by Replica Plating 
Replica plating of the genomic DNA library was carried out according to the replica 
plating protocol found in Current Protocols (66). Aliquots of 100 JJL of diluted genomic 
DNA library stock (dilution 1/10,000 to give between 50 and 100 colonies per 100 mm 
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diameter plate) were plated out onto 20 LB agar plates containing ampicillin (50 /jg/mL). 
These plates were grown overnight at 37°C and used as master plates. Colonies from the 
master plates were transferred to sterile velveteen squares (Scienceware) and replica 
plated onto minimal agar plates (1 % wt/vol minimal media (Difco), 1 mM proline, 1 mM 
thiamine-HCl, 50 /Jg/mL ampicillin, 1.5 % w/v agar) with and without 0.5 M IPTG. All 
plates were grown overnight at 37°C. 
Colonies grown on plates with IPTG were compared to the colonies grown on plates 
without IPTG to determine if gene suppression had occurred. Those colonies that grew on 
the plates containing IPTG that did not grow or that grew slower on plates without IPTG 
were isolated for further analysis. 
Isolation and Analysis of Plasmid Vector 
Isolation of the plasmid vectors that contained genomic DNA inserts was carried out 
using a scaled down version (from 500 mL to 100 mL ) of the large-scale plasmid preps 
found in Protocols and Applications Guide from Promega (57). The colonies found on 
minimal plates without IPTG that corresponded to those colonies that did not grow or 
grew slower on minimal plates with IPTG were selected and their plasmids isolated by 
the method mentioned above. 
Restriction digests were used to determine if genomic DNA inserts were incorporated 
in the vector. These reactions contained 1 /jg of plasmid DNA, EcoR I and Hind III at 
1.0 units/jjg DNA for each restriction enzyme (New England Biol.) and 1.0 /JL of 10X 
restriction enzyme buffer in a final volume of 10 yL. The reactions were incubated 
overnight at 37°C, and the restriction fragments were separated and visualized by agarose 
gel electrophoresis. 
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DNA Sequencing and Analysis 
DNA sequencing procedures were carried out according to the protocol included in 
the 77 Squenase 2.0 sequencing kit (Amersham Life Sciences). This protocol is based on 
the Sanger dideoxynucleotide sequencing method (67). The primers used were 
complementary to either the T7 RNA polymerase promoter or the SP6 RNA polymerase 
promoter. The isotope used was [«- j3S] dATP with a specific activity of 1000-1500 
Ci/mmol. The gel was exposed to X-ray film (Fuji) for 5 days. The film was developed in 
GBX developer for 2 minutes and GBX fixer for 5 minutes. 
DNA sequences were compared to the E. coli sequence database (56) using the blast 
search program (68). E. coli sequences that matched to isolated GSE insert sequences 
were analyzed to ascertain the type of GSE that was involved in possible gene 
suppression. The main characteristic used to determine the type of GSE involved was 
accomplished by determining the orientation in which the GSE sequence matched to the 
E. coli gene sequences. Sequences matching in the sense orientation were considered 
dominant negative mutant GSEs. Those sequences matching in the antisense orientation 
were considered antisense RNA GSEs. 
RNA Secondary Structure Analysis 
The RNA secondary structure for each gene was predicted using an RNA folding 
algorithm from Mathews el. al. (69). This algorithm is based on free energy minimization 
using the nearest neighbor parameters. Predicting a structure is a two-step process. First, 
a recursive algorithm generates an optimal structure and a series of structures that are 
called sub-optimal structures (69). The number of sub-optimal structures generated is 
controlled by three parameters determined by the user, maximum % energy, maximum 
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number of structures, and window size. Maximum % energy sets the percent difference 
from the lowest free energy allowed for the structure output. Maximum number of 
structures sets an absolute upper limit on the number of structures (1000) that can be 
generated. Window size controls how different the sub-optimal structures must be from 
each other. A small window size allows very similar structures to be generated while a 
larger window size requires them to be more different (69). 
Second, structure favorability is re-ordered. Here, the energy of each structure is re-
calculated using a function that includes coaxial stacking of helixes and a Jacobson-
Stockmayer function for determining the free energy of large loops. The output is then 
sorted according to the recalculated free energy (69). The parameters used to create 
localized RNA secondary structures for those E. coli genes that matched to any GSE 
transcripts produced in this study are as follows: Max % energy difference = 10, Max 
number of structures = 1000 and Window size = 3. 
Results 
Isolation, Linearization and Dephosphorylation of pAV Vector 
The pAV vector was isolated from a large-scale plasmid preparation of 500 mL of 
cells. The plasmid DNA was purified to a 260nm/280nm ratio value of 1.79 and gave a 
yield of lmg of purified plasmid DNA. 
The vector pAV was linearized using 200 units BamH I restriction enzyme per 400 
)jg of pAV in a 300 /uL reaction. The reaction was incubated at 37°C overnight. 
Linearization was determined by agarose gel electrophoresis and a 3000 bp fragment was 
obtained (Figure. 3 lane 3). 
Dephosphorylation of pAV was a critical step in preventing any religation of the pAV 
vectors to itself. A total of 200 jug of linearized pAV vector was dephosphorylated with 
16 units of shrimp alkaline phosphatase in a 200 fjL reaction. The reaction was incubated 
at 37°C for 1 hour and heated to 65°C water bath for 15 minutes to inactivate the shrimp 
alkaline phosphtase. 
A test ligation was performed to determine if the dephosphorylation of pAV was 
efficient. The control ligation contained 200 ng of linear, dephosphorylated pAV without 
ligase in a 10 /^L reaction, and the experimental ligation contained 200 ng linear pAV 
with ligase. Both reactions were incubated at 16°C overnight and analyzed by agarose gel 
electrophoresis (Figure 3, lanes3 & 4, respectively). 
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26 
1 2 3 4 5 6 
-3000 bp 
-2000 bp 
-1600 bp 
-1000 bp 
-500 bp 
Figure 3. Gel electrophoresis of linearized pAV, and partially digested E. coli JM109 
DE3 genomic DNA. The electrophoresis was carried out on a 0.8 % w/v agarose gel. 
Lanes 1 & 6 are lkb markers (BRL). Lane 2.Uncut pAV: Lane 3. Linear pAV; Lane 4 
shows dephosphorylated pAV after self-religation: Lane 5. Partial digestion of JM109 
DE3 genomic DNA after 3.0 hours: 
Isolation and Partial Digestion of E. coli JM109 DE3 Genomic DNA 
Genomic DNA was isolated from a 500 ml overnight culture of E'. coli JMI09 DE3. 
Purification of the JMI09 DE3 genomic DNA was performed using a cesium 
chloride/ethidium bromide gradient and centrifuged at 145,000 x g for 24 hours. The 
ethidium bromide was extracted with water-saturated butanol, and the cesium chloride 
was removed by dialysis. A yield of 175 /jg of genomic DNA was obtained with a 
260nm/280nm ratio of 1.81. 
JM109 DE3 genomic DNA (175 /jg) was digested with 50 units of Sau3A 1 restriction 
enzyme in a total volume of400 /jL. Aliquots of 10 JJL were drawn at 1.0 hour intervals, 
and the progress of digestion was determined by gel electrophoresis. Figure 4 shows the 
partial digestion at 1.0 hour and reveals that the majority of the JM109 DE3 genomic 
DNA fragments lie between 6000 and 1000 bp. Figure 5, at 2.0 hours of digestion, shows 
a range of fragments from approximately 3500 bp to 400 bp. A partial digestion for 3.0 
hours was found to generate the majority of the DNA fragments between 1000 bp and 
250 bp which was the desired fragment range (Figure 6). 
Fragmented JM109 DE3 genomic DNA was purified by phenol extraction/ethanol 
precipitation. The fragmented genomic DNA was size fractionated (130 jug in 280 ijL) on 
a CL-4B Sepharose column and fractions of 170 /JL (5 drops) were collected. A 10 IJL 
aliquot was removed from each fraction, and fragment sizes were determined by gel 
electrophoresis (Figure 7). Fractions 13-16 were pooled and purified by phenol 
extraction/ethanol precipitation and used in the ligation to the pAV vector. 
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Figure 4. Electrophoresis of a 1.0 hour Sau3A digestion of JM109 DE3 genomic 
DNA on a 0.8 % agarose gel: Lane 1 & 4: lkb marker (BRL). Lane 2: uncut JM109 
DE3 genomic DNA. Lane 3: DE3 genomic DNA partially digested for 1.0 hour. 
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Figure 5. Electrophoresis of a 2.0 hour digestion of JM109 DE3 genomic DNA on a 
0.8 % agarose gel: Lane 1 & 3: Ikb marker (BRL). Lane 2: partially digested JM109 
DE3 genomic DNA. 
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Figure 6. Electrophoresis of a 3.0 hour Sau3A digestion of JM109 DE3 genomic 
DNA on a 0.8 % agarose gel. Lane 1: DE3 genomic DNA partially digested after 3.0 
hours. Lane 2: lkb marker (BRL). 
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Figure 7. Electrophoresis of fractionated JM109 DE3 genomic DNA on a 0.8 % 
agarose gel: Lane 1 & 21: lkb markers (BRL). Lanes 2-11: No DNA resolved in 
fraction. Lanes 12-20: Fractions volumes of 170 pL were collected from CL-4B 
sepharose column. Fractions 13 through 16 were purified and used for the ligation 
reaction. These fractions were chosen because the DNA fell within the desired fragment 
range of approximately 50 to 1500 bp. 
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Ligation and Transformation of DE3 genomic DNA to pAV 
Ligation reactions incorporated six controls and two experimental reactions as 
illustrated in Table 1. Control 1 contained 10 iL water, control 2 contained uncut pAV, 
serving as a negative and positive transformation controls, respectively. Controls 3 and 4 
contained linear pAV without and with T4 DNA ligase, respectively. These controls 
tested the overall ligation efficiency and the ability of linear pAV to self-Iigate. Controls 
5 and 6 consisted of dephosphorylated pAV, with no T4 DNA ligase and with T4 DNA 
ligase, respectively. These controls determined the dephosphorylation efficiency by 
testing the ability of dephosphorylated pAV to self-ligate in the presence of T4 DNA 
ligase. Two experimental ligation reactions were set up with a 1:1 molar ratio of vector to 
insert and a 1:2 molar ratio of vector to insert. 
A 3 juL aliquot was taken from each control and experimental reaction and 
electrophoresed to determine the ligation status (Figure 8). Dark bands in figure 8 greater 
than 4000 bp, illustrate JM109 DE3 fragments ligated into the dephosphorylated pAV 
(Figure 8 lanes 11 & 12). In contrast, the dephosphorylated vector did not ligate (Figure 
8, lanes 9 & 10) and no bands above 5000 bp were obtained. Linearized pAV controls 
showed a faint band in control 3 (Figure 8 lane 6) and no distinct bands for control 4 
(Figure 8 lane 8). 
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Table 1. Components used in ligation reactions. 
control 1 control 2 control 3 control 4 control 5 control 6 Ligation-1 Ligation-2 
No vector Uncut 
pAV 
Linear 
pAV 
no ligase 
Linear 
pAV 
With 
ligase 
Dephosph 
pAV 
no 
hgase 
Dephosph 
pAV 
with 
hgase 
JM109 
DE3 
1:1 
molar 
ratio 
JM109 
DE3 
1:2 
molar 
ratio 
PAV 
200ng 
lyL 
200ng 
ILJL 
200ng 
1/JL 
200ng 
l^L 
200ng 
4vL 
l^g 
4nL 
l^g 
JM109 
DE3 
Fragment 
1/JL 
181ng 363ng 
T4 
buffer 
l^L lvL \UL 
lOx 
T4 
Ligase 
*
>
-
10 W/JUL 
2fuL 
10 ut[i L 
2liL 
10 W//JL 
2(jL 
10 u/yL 
DH2O 9jjL 6^L 6/JL 2/JL IJJL 
Totals 10/JL 10/JL 10/JL 10^L 10^L 10(jL \o^L 10/uL 
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Figure 8. Electrophoresis of ligation reactions on a 0.8 % Agarose gel: 
Lanes 1,7 & 13: 1 kb markers (BRL). Lane 2: uncut pAV. Lane 3: linear pAV. Lane 4: 
No vector. Lane 5: Uncut pAV. Lane 6: linear pAV without ligase. Lane 8: Linear pAV 
with ligase. Lane 9: Dephosphorylated pAV without ligase. Lane 10: Dephosphorylated 
pAV with ligase. Lane 11: a 1 :lmolar ratio experimental ligation. Lane 12: a 1:2 molar 
ratio experimental ligation. Lanes 15 & 16: previous experimental ligations. Lanes 2 and 
3 are controls that did not go through the ligation reaction and were used for comparison 
to lanes 5 and 6. 
Once successful ligation was confirmed, the ligation mix was transformed into 
E. coli JM109 DE3 cells. Transformation was carried out by electroporation using 0.5 ng 
of recombinant pAV added to 100 /jL electrocompetent DE3 cells. Transformation 
efficiency and titer were determined by serially diluting transformed cells and plating 100 
IJL of the diluted cells onto 7 LB/ampicillin (50/jg/^L) agar plates per reaction. All plates 
were incubated at 37°C overnight and colonies counted. 
Table 2 shows the number of colonies per plate and the resulting transformation 
efficiencies and titer. Transformation with the negative control (No vector) produced no 
colonies and the positive control (uncut pAV) produced the most colonies with a 
transformation efficiency of 109 (Table 2). Analysis of transformation efficiencies for 
linear pAV without ligase vs linear pAV with ligase shows that linear pAV was able to 
religate to produce efficiencies rivaling the uncut control, thus indicating that the ligation 
efficiency was very good. 
Examination of the dephosphorylated pAV with and without ligase shows that 
dephosphorylated pAV was able to religate to some degree and therefore not all of the 
pAV molecules were dephosphorylated and will appear as unproductive background. 
Unproductive background clones in the 1 :land 1:2 libraries appear at the rate of 14 % 
and 10 % respectively (Table 2). Transformation values obtained for the 1:1 and 1:2 
molar ratio of vector/insert were comparable to the control values for uncut pAV and 
religated linear pAV (Table 2). This similarity is an indication that the ligation of 
dephosphorylated pAV and DE3 genomic inserts were successful, and contained a low 
background (10 — 14 %) for dephosphorylated pAV self ligation. 
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Table 2. Transformation Results. 
Dilutio 
n 
No vector Uncut 
pAV 
Linear 
pAV 
no ligase 
Linear 
pAV 
With 
hgase 
Dephosph 
PAV 
No 
Ligase 
Dephosph 
pAV 
with 
ligase 
1:1 1:2 
IO-1 0 TNTC 17 TNTC >300 >300 TNTC TNTC 
0 TNTC 0 TNTC 21 76 TNTC TNTC 
0 >300 0 >300 7 15 101 145 
10-4 0 29 0 18 0 4 11 23 
10* 0 6 0 1 0 0 2 3 
10-6 0 0 0 0 0 0 0 0 
* 
Transform 
Efficiency 
CFU/ug 
D N A 
0 6.4 x 109 3.7 x 106 4.0 x 109 4.6 x 107 1.7 x 108 2.4 x 109 3.3 x 109 
* * 
Titer 
CFU 
PermL 
0 2.9 x 10* 
in a total 
of 1 mL 
1.7 x 103 
in a total 
of 1 mL 
1.8 x 106 
in a total 
of 1 mL 
2.1 xlO4 
in a total 
of 1 mL 
7.6 x 104 
in a total 
of 1 mL 
1.1 xlO6 
in a total 
of 1 mL 
1.5 xlO6 
in a total 
of 1 mL 
* Colony forming units = CFU 
* Titer = CFU/mL = # colonies / (dilution) (0.1) 
** Transformation efficiencies = CFU/mL x 1.1 mL / 0.5 ng x 10"3 yg / ng 
• TNTC = too numerous to count 
• After electroporation, 100 JJL of each transformation was serially diluted to 10"10. 
From each dilution, 100 /jL of cells were plated onto LB/ampicillin plates 
(50 /jg/mL) and incubated overnight at 37°C. The number of observed colonies for 
each treatment and dilution is shown above. CFU/mL was calculated for the titer of 
the original 1.1 mL of electroporated cells. Transformation efficiency was based on 
the 0.5 ng of DNA used in each transformation. 
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Amplification and Titer of GSE Library 
The recombinant library with the 1:2 molar ligation ratio was amplified to a titer of 
7.0 x 109 colony-forming units (CFU) per mL in a total volume of 35 mL to yield 
2.45 x 10" CFUs total. A comparison of the GSE library before amplification and after 
amplification shows a marked increase from 1.5 x 106 CFUs in a total of 1 mL to 
2.45 x 1011 CFUs in a total of 35 mL and 7.0 x 109 colony-forming units CFUs per mL. 
These figures represent a 4,666 fold increase of CFUs per mL of GSE library and a 
163,333 fold increase overall. 
Analysis of the GSE Library 
From the amplified GSE library, DNA from 2 clones were isolated and cut with a 
EcoR I / Hind III double digest to reveal an average insert size of 60 bp. With this insert 
size and a total CFU in the unamplified library of 1.5 x 106, the current GSE library is 
200 % representative of the E. coli genome. 
Screening of the GSE Library 
The GSE library was screened by plating a 100 juL aliquot of 1/100,000,000 diluted 
genomic DNA library stock onto 20 LB agar plates containing ampicillin (50 ^g/mL). 
These plates were grown overnight at 37°C and used as master plates. Colonies from the 
master plates were transferred to sterile velveteen squares and were replica plated onto 
two minimal agar plates, one with EPTG and one without IPTG. 
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Plates were grown overnight at 37°C and colony growth on the minimal plates with IPTG 
were compared to the colony growth on the minimal plate without IPTG to determine if 
genetic suppression had occurred. 
Those colonies on the plates containing IPTG that did not grow or that grew slower 
than colonies on the plates without IPTG were isolated for further analysis. A total of 850 
colonies were screened resulting in 12 colonies expressing GSE characteristics. 
Characterization of Potential GSE Clones by Restriction Digestion 
DNA was isolated from the 12 colonies that exhibited slow growth or no growth in the 
presence of IPTG. DNA from each colony was digested with EcoR I and Hind III (New 
England Biological) to excise any insert ligated into the BamH I site. Restriction digests 
revealed that 2 of the colonies harbored detectable inserts. These colonies, A21 and A41, 
were chosen to be sequenced. DNA from both colonies was isolated and analyzed by 
restriction digest once more. 
Figure 9 shows the restriction patterns of the plasmids isolated from the colonies A21 
and A41. The plasmid isolated from the A21 colony produced a fragment of 
approximately 120 bp when double digested with EcoR I / Hind III and no detecable 
fragments when digested with EcoR I or Hind III alone. Also, digestion of the A41 
plasmid with EcoR I/Hind III double digest produced a fragment of approximately 90 to 
100 bp. Digestion with EcoR I or Hind III alone did not yield any detectable fragments 
for the A41 plasmid. 
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Characterization of Potential GSE Clones by DNA Sequencing 
DNA sequencing was used to further characterize the plasmids isolated from the 
colonies A21 and A41. DNA sequencing was initiated using a primer specific for the T7 
or the SP6 RNA polymerase promoters that lie on opposite sides of the multiple cloning 
site into which GSE fragments were inserted. The sequencing data in figure 10 shows 
that the A21 vector harbors a 76 bp insert. Comparison of the A21 DNA sequence to the 
E. coli genomic sequence database (56) determined that colony A21 matched 20 E. coli 
genes. However, the sequence matches between the A21 insert and the E. coli genes 
contained approximately 13 % undetermined bases or N's. Subsequently, no further 
investigation was performed until additional sequencing could be done. 
The A41 complete transcript harbors a 44 bp insert (Figure 11) and matches seven E. 
coli genes (Table 3). The bases that matched these genes all lie within the insert sequence 
of A41.Upon further analysis the A41 transcript potentially binds to all seven E. coli 
genes in the antisense orientation. Also, all A41 binding sites are GC rich and some have 
identical binding sequences. Examination of the location and interaction between the A41 
transcript and each individual mRNA produced by these genes was essential to 
understanding the processes for potential gene suppression. 
Determination of Antisense Inhibition Mechanism 
To determine the possible mechanisms involved in the suppression of each of the 
seven mRNA transcripts, the location and potential secondary structure was determined. 
Examination of each of the seven A41 binding sites showed that they are located in the 
coding domains of each of the genes (Figure 12). These findings eliminate the class la 
mechanism that requires binding of antisense RNA such that it overlaps the Shine-
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Dalgarno ribosomal-binding site. It also eliminates the class II mechanism that requires 
binding upstream of the ribosomal-binding site. Left, then, is the possibility of a class lb 
mechanism, in which antisense RNA binds to the coding region and destabilizes it by 
increasing nuclease degradation of the mRNA, the class III mechanism, in which binding 
of the antisense RNA induces premature transcriptional termination by mimicking a 
transcription termination site. Since this study did not include a northern analysis to 
determine the size or stability of target mRNAs, the possibility that a class lb mechanism 
is the source of inhibition can not be eliminated. However, analysis of the predicted 
secondary structure with and without antisense RNA bound to potential target sites will 
allow us to predict if a class III type of inhibition is a possible mechanism. Such 
predictions can be confirmed by a northern analysis. 
Characterization of Potential GSE Mechanisms by RNA Secondary 
Structure Analysis 
It must be noted that a predicted RNA structure for each gene must incorporate 
approximately 500 bases to be 73 % accurate. Therefore, the RNA secondary structures 
predicted here for each gene may or may not exist in nature. The intention is to illustrate 
the localized (50 to 60 bp) mRNA secondary structure of each gene in its unbound state 
and to show the subsequent disruption of local mRNA secondary structure for each gene 
when the A41 transcript is bound. These steps must be done to confirm the presence, if 
any, of structural interruptions occurring because of the antisense RNA binding. 
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Figure 9. Electrophoresis of restriction digest products from the plasmids isolated 
from the colonies A41 and A21. Digestions were electrophoresed on a 0.8% agarose gel 
for 1 hour at 100 volts. The first and last lanes consist of lkb marker (BRL). Digests were 
ordered on the gel as follows: (A) uncut plasmid, (B) EcoR 1 digest, (C) Hind III digest 
and (D) double digest with EcoR I and Hind III. 
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T7 Proraotar Insert TIAATACGACTCACTATAGGGAGACCGG AATTCOAGCTCGGTACCCGGQ XTTXTGCTGXSTGXT».TCCXrCTIJGCCTTAX GCTCGXGCCXTOSGCCCCTAG GAt^TCTCKSCTTTNCGTCCGTACaCCCGGNNTTCTTHNCC 
Ball B«mH I Bind III 
Xnaart ATTHACTN^GOTOTTCWCTCMTTTTCGGG GATCCTCTAGAGTCGACCTGCACGCATGCA AGCTTCASTATTCTATAGTGTCACCTAAATC 
TAANTGAMCNCCHOtCCOACCCXAAAGCCCCTAa (^0*TCTCJLGCT0G»CGTCCCT*CGTTCS» ACTCATAAGATATCACAQTGGATTTAG 
SP6 Promoter 
T7 Taminator Start 
CCA«^ T<»TCra»OTCCT»A£AAAIKCCaUUUMAAGCT«^ ^ GGTC(3AACTAJ5GCCGACGATTGTTTCGGGCT ITCCTTCGACTCAXCCGACGACGGTGGCCSACTCGTTATTCiAirGTA 
3' gGGGCCTCTAAACGflCTCTTSAGCG^'l TTJ. TiGCTSKAAGGACGAHCT CCCCGGAGA.TTTGCCCA.tiAACGCCCCAAAAAACGA.CTTTCCTCCANGA 
Figure 10. A21 Full Transcript Sequence: A21 plasmid DNA sequence was determined 
using the T7 RNA and the SP6 polymerase promoter primers. The A21 insert contains 
13 % unknown bases that are incorporated within the sections of the insert that possibly 
bind to 20 E. coli genes. 
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A«1 Full Transcript. 
5' EcoR ? fit* Half ButH 1 HU Hfclf ButK I uta T7 Profnot»r Insert ATTAATACSACTCACTATAOOSAaACCCC AATTCGAGCTCGOTACCCGGG (»TCOIu:CGCCGCCCGCGO«»KJlTCCCGJlGCTGCGCTC GATCCTCT TAATTATGCTGAGTGATATCCCTCTGGCCTTAA GCTCGAGCCATGCGCCCCTAi: CTGCCCOCGGGCGCGCCGCGTACCSCTCGJiCGCQASCTJlG CASA 
Hind III iiu 
ASAGTCGACCTGCAOGCATGCA AGCTTGAGTACTCTATAGTGTCACCTAAATCCCAGCW(^TCCG<2CTGCTAACAAAflCCCGAAAXMAAGCTGAGTTG TCTCAGCTGOACGTCCGTACGITCGA ACTCATAAiaTATCACACTG^TTTAjCSGGTCGAACTAGCCCOACSATTCOTTCSGCC'l'l'l'CTTCGACTCAAC 
SP€ prcoot«r 
T7 Ternunator -
BCrGCTOCCACgSCTliA^  
CC^ GACaGTOGCGACTaTrTATTraTa^ TTRXraUUX^  
Figure 11. A41 Full Transcript Sequence: A41 plasmid DNA sequence was determined 
using the T7 and the SP6 RNA polymerase promoter primers. 
Table 3. Possible gene matches between the A41 transcript and the E. coli genome 
Gene Function Product 
rtarZ Energy metabolism carbon, 
anaerobic respiration 
Cryptic nitrate reductase 2 
Alpha subunit 
narG Energy metabolism carbon, 
anaerobic respiration 
Nitrate reductase 1 
Alpha subunit 
fepG Transport: transport of small 
molecules 
Ferric enterobactin 
Transport protein 
Ihr Enzyme, DNA replication and 
repair 
Member of ATP-dependent 
Helicase superfamily n 
yahl Putative enzyme Putative kinase 
yxfG Putative enzyme Putative enzyme 
ycjQ Putative enzyme Putative oxidoreductase 
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lhr SD 
narG SD 
narZ ?D 
A41 
A41. 
A41. 
4617 bp 
3743 bp 
.3740 bp 
fepG SD 
,A41 
. 932 bp 
ysrc 
ycjQ 
SD 
SD 
•A41 
A41. 
.827 bp 
.1057 bp 
yahl SD 
1 
A41. 
-950 bp 
Figure 12. Area of localized binding of the A41 Transcript to each of the seven E. 
coli mRNAs 
The lhr gene codes for a 4617 bp mRNA transcript that functions as an enzyme. It is a 
member of the ATP-dependent helicase super family II and is involved in DNA-repair, 
replication, restriction and modification. Localized folding of the lhr transcript in its 
unbound state produces a short lead sequence followed by two stem loop structures. The 
stem loop structures are bonded together at the 3' end of the first stem loop to the 5' end 
of the second stem loop. (Figure 13). Localized folding for the lhr transcript in its bound 
state show a marked difference in secondary structure (Figure 14). When bound by the 
A41 transcript, thelhr transcript is folded into a structure that combines the two stem 
loop structures that are seen in figure 13. A two base section follows the stem loop 
structure and precedes the area of complementary base pairing between thelhr transcript 
and the A41 transcript. Nine A/U's follows the bound region at the 3' end of the 
transcript. The interaction between the A41 transcript and th elhr transcript has the 
characteristics of Class III antisense mechanisms. Binding of the A41 transcript induces 
a change in th elhr mRNA secondary structure and produces a long GC rich stem 
structure. This change in secondary structure from a short (6 bp) GC rich stem loop to a 
very long (15 bp) GC rich stem structure which may cause the RNA polymerase to stall 
and possibly dissociate because of the 9 contiguous A U base-pairs following the mRNA 
duplex. Such premature transcriptional termination would produce a truncated protein 
that would consist of only its N-terminal domain of the protein. 
The narG gene codes for a 3743 bp mRNA transcript that functions as an enzyme. It 
codes for the alpha subunit of nitrate reductase 1 and is used for energy metabolism. 
Localized folding of the narG transcript produces a complex secondary structure (Figure 
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15). The A4I transcript binds within the middle of the narG transcript were localized 
folding for the narG transcript in its A41 hybridized state shows a distinctly different 
secondary structure (Figure 16). When bound by the A41 transcript, the narG transcript 
is folded into a structure that combines the two stem loop structures that are seen in figure 
15. The area of complementary base pairing between and the A41 transcript the narG 
transcript closely follows the stem loop structure and precedes a section rich in Gs and 
Cs. Binding of the A41 transcript to the narG transcript would have the characteristics of 
a Class III antisense mechanism if the sequence following the duplex were A/U rich; 
however, the 10 bases following the duplex are 70% GC and therefore would not be an 
effective Rho-independent terminator. 
The narZ gene codes for a 3740 bp mRNA transcript that functions as an enzyme. It 
codes for the alpha subunit of the cryptic nitrate reductase 2 and is used for energy 
metabolism. Localized folding of the narZ transcript produces a complex secondary 
structure (Figure 17). The A41 transcript binds within the middle of the narZ transcript 
were localized folding for the narZ transcript when bound to A41 shows a distinct 
difference in secondary structure (Figure 18). When bound by the A41 transcript, the 
narZ transcript is folded into a structure that combines the two stem loop structures 
shown in figure 17. The A41 and the narZ transcripts precede a 10 bp section of single 
stranded RNA that is 70 % G/G and would not serve as a Rho-independent terminator. 
The fepG gene codes for a 932 bp mRNA transcript that functions as a protein. It 
codes for the ferric enterobactin transport protein and is used for the transport of small 
molecules. Localized folding of the fepG transcript produces a complex secondary 
structure (Figure 19). The 5'end consists of a large hairpin with three bulges and the 3' 
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end has a short hairpin. The A41 transcript binds 200 bp downstream of the fepG 
transcript's 5* end where localized folding for the fepG transcript when bound to A41 
shows a similar secondary structure (Figure 20) with only the 3' stem-loop removed. 
Base pairing between and the A41 transcript and the fepG transcript precedes a section of 
single stranded bases that are 60 % A/U. Even though the stem region is strong and GC 
rich, this single stranded tail would not be sufficiently weak to allow Rho-independent 
transcriptional termination. 
Th eygfG gene codes for an 827 bp mRNA transcript that has a putative function and 
codes for a putative enzyme. Localized folding of th eygfG transcript produces a complex 
secondary structure (Figure 21) that is a long stem-loop structure with interior bulges. 
The A41 transcript binds 80 bp upstream of the ygfG transcript's 3' end where localized 
folding for the ygfG transcript hybridized to the A41 shows a distinctly different 
secondary structure (Figure 22). When bound by the A41 transcript, the ygfG transcript 
is folded into a structure that shortens the original stem structure by eliminating the first 
four bulges and creates a long 5' leader sequence. The area of complementary base 
pairing between the A41 transcript and th eygfG transcript is bound directly to the base of 
the stem loop structure and precedes a section of single stranded RNA that has a 60 % 
A/U composition. The A41 transcript binds close to the 3' end of the ygfG transcript and 
only 110 bp upstream from theyg fH start site. The close proximity upstream to the ygfH 
start site affords a possibility of class II suppression of the ygfH gene. 
The ycjQ gene codes for a 1052 bp mRNA transcript that has a putative function and 
codes for a putative oxidoreductase. Localized folding of the ycjQ transcript produces a 
small hairpin loop structure that is bound adjacent to a larger hairpin loop. (Figure 23). 
49 
Ihe A4i transcript binds 205 bp downstream of the yc/O transcripts 5" start site where 
localized folding for the yc/O transcnpt in its A41 hybridized state (Figure 24) produces 
a structure that combines the original two hairpin loops into one GC rich hairpin. The 
A41 transcript and the ycj(J transcripts are "bound together three nucleotides from the base 
of the hairpin loop structure and form a G/C rich 14 bp hybrid. The 10 "bases downstream 
of this hybrid are 70 % A/U rich. 
The yahl gene is a 950 bp mRNA transcript that codes for a putative kinase. Localized 
folding of Xheyahl transcript produces a large hairpin loop structure (Figure 25). The 
A41 transcript "binds 350 bp upstream of the yahl transcripts 3' end were localized 
folding for the yah] transcnpt in its A41 hybridized state (Figure 26) rearranges the 
folded structure into AU rich hairpin. The A41 and the yahl transcripts are "bound 
together 1 nucleotide from the base of the hairpin loop structure and form a 14 bp hybrid. 
The i0 "bases following the hybrid are only 40 % A/U rich and would not serve as a Rho-
independent termination site. 
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Figure 13. The I hr mRNA unbound by the A41 Transcript. 
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Figure 14. The A41 Transcript bound to the 1 hr mRNA. 
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Figure 15. 1 he narG mRNA unbound by the A41 Transcript. 
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Figure 16. A41 Transcript bound to the narG mRNA. 
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Figure 17. The narZ mRNA unbound by the A41 Transcript. 
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Figure 18. A41 Transcript bound to the narZ mRNA 
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Figure 19. The fepG mRNA unbound by the A41 Transcript. 
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Figure 20. A41 Transcript bound to the fepG mRNA. 
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Figure 21. Theyg fG mRNA unbound by the A41 Transcript. 
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Figure 22. A41 Transcript bound to theyg fG mRNA. 
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Figure 23. TheycjQ mRNA unbound by the A41 Transcript. 
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Figure 14. The A41 Transcript bound to the 1 hr mRNA. 
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Figure 25. Thevahl mRNA unbound by the A441 Transcript. 
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Figure 14. The A41 Transcript bound to the 1 hr mRNA. 
Discussion 
Plasmid based clones of genetic suppressor elements (GSEs) encoding either 
dominant negative mutants or inhibitory antisense RNA sequences can be generated from 
randomly fragmented DNA and selected by observed suppression of functional gene 
expression (2). The goal in this study was to determine if gene inhibition in E. coli 
JM109DE3 cells could be achieved through GSEs generated from randomly fragmented 
genomic DNA and whether these GSEs can be used to locate and determine the function 
of unknown genes. The results suggest that it is possible to use genetic suppressor 
elements to inhibit gene function in bacterial cells and to isolate genes with unknown 
function. 
Data in figure 7 demonstrated that a selection of DNA fragments ranging in size from 
approximately 50-1500 bp were cut and isolated from genomic DNA. Figure 8, lane 12, 
shows that these fragments were successfully ligated into the pAV vector, and Table 2 
shows transformation results that predict that 90 % of the 1.5 x 106 initial clones were 
recombinant. Amplification of the GSE library increased this amount to a total of 2.45 x 
10n CFUs. Screening of the library for auxotrophic genetic suppressors revealed 2 
independent GSE isolates out of 850 colonies. To truly characterize this library, a gene 
that represents a certain percentage of the entire E. coli JM109DE3 genome would be 
used to probe the library. This gene probe would determine if the library contained the 
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proper proportion of this particular gene. This procedure was not done due to the lack of 
time. 
A DNA sequencing analysis of each GSE isolate determined that A21 harbored an 
insert of 76 bp (figure 10) and matched to 20 E. coli genes. However the probability of 
these matches occurring by chance was very high. The area of concern for the A21 insert 
was that it contained 13 % unknown base pairs within the section of sequences that 
matched to the 20 E. coli genes. These unknown bases produced less accurate sequencing 
data to be matched against the E. coli genome database. The fact that JM109DE3 E. coli 
cells that harbored the A21 transcript exhibited GSE suppression characteristics suggests 
the A21 insert produced a GSE. More accurate sequencing data will be needed to 
determine if the A21 insert can match to E. coli genes and significantly decrease the 
probability of chance. 
The A41 transcript contained a 44 bp insert (Figure 11) and was found to be 
complementary in sequence to seven different E. coli genes. Examination of the localized 
RNA secondary structure folds for each gene located the area of complementary base 
pairing of the A41 insert. Analysis of this site for each RNA structure allowed the 
opportunity to establish a possible antisense RNA mechanism. In all of the seven genes 
analyzed, the A41 antisense RNA was found to hybridize within the coding region for 
each gene. These data eliminated the Class la and Class II antisense RNA mechanisms. 
Antisense inhibition of all seven genes by the A41 transcript may occur through 
cleavage of the mRNA/antisense RNA duplex by RNaselll (Class lb). Antisense control 
of AcII expression by the oop antisense RNA appears to result exclusively from RNaselll 
cleavage of the target mRNA / antisense RNA complex (25, 29, 44). RNaselll 
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participates in the maturation and decay of cellular and viral transcripts by degrading 
double-stranded RNA. Also, RNase III degradation is inherent to most antisense RNA-
regulated gene systems in E. coli (70). The typical cleavage sites for RNase III are the 
internal loops found within a stem-loop structure (71). The RNA secondary structures for 
each of the seven genes that are bound by the A41 insert (Figures 14, 16, 18, 20, 22, 24, 
26) show that each form a stem-loop which have internal loops incorporated. These sites 
provide a possible cleavage site for RNase III. 
The last antisense RNA mechanism to be considered is Class III. Here, antisense 
RNAs bind to a target sequence and disrupt the nascent mRNA secondary structure so 
that transcription is inhibited by a mechanism similar to transcriptional attenuation. In 
nature, a complex mechanism is proposed for the pT181 antisense RNA, where antisense 
RNA binding causes a detrimental conformational change in the mRNA (25). 
According to Wilson and von Hippel (72), the optimal hairpin dimensions for 
maximizing termination efficiency for intrinsic, rho-independent terminators consist of a 
stem structure with 8 or 9 mostly GC base pairs and a loop of 4 to 8 bp. They also found 
that lengthening or shorting the stem beyond these limits would decrease or abolish 
terminator activity. Another important characteristic that Wilson and von Hippel 
detected was that the site of termination is invariant, meaning that in each variation of a 
wild-type terminator (tR2) that they had tested, termination occurred at the exact same 
position. This area was within or at the end of a stretch of U's located on the 3' end of the 
hairpin where termination always occurred at the 7th and 8th U (72). 
The data of Wilson and Hippel was used to determine if the hairpin structures 
produced in this study were true Class III rho-independent terminators. Examination of 
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all seven of the E. coli genes bound by the A41 insert determined that only lhr exhibits 
some of the required characteristics for intrinsic termination. The hairpin structural 
dimensions produced for the lhr (Figure 14) are as follows: 1) The stem structure 
consists of 14 bp bonds where 12 of the bonds are GC. 2) The loop of the hairpin is made 
up of 6 bp. 3) A stretch of 9 A/U incorporated adjacent to the A41/lhr mRNA hybrid 
where the seventh and eighth residues are A A. The hairpin stem structure dimensions 
exceed the 8 to 9 bp, but fall within the range of 4-8 loop bp with 6 bp. The seventh and 
eighth residues downstream of the A41/lhr hybrid are A A and do not adhere to the 
U7/U8 criteria. The comparison of the A41/lhr hybrid to the Wilson/ Hippel model 
suggests that the probability of the A41/lhr hybrid acts as a Class III mechanism is low. 
The hairpin stem is too long by Wilson/Hippel criterion and more importantly the 
residues at the seventh and eighth positions adjacent to the 3' end of the hybrid are A A 
vs U U. Wilson and Hippel suggest that the stretch of rUs downstream of the hairpin 
stem is essential to provide the necessary level of RNA-DNA destabilization (72). 
The insert size for both the A21 and A41 clones were unexpectedly short. Two 
Factors were involved. First, the fractions of fragments isolated by size using the CL 4B 
sepharose column were found to be between approximately 50 to 1500 bp (Figure 17). 
Fraction 16 shown in figure 7 illustrates that there were small fragment sizes incorporated 
into the pool of fragments collected and would allow a small vector such as the pAV used 
in this study to ligate to the smaller fragments at a more efficient rate as opposed to the 
larger fragments. Also, given that only a small fraction of the entire library was tested 
would in itself be a factor in that the first clones detected would be those clones that 
harbored the smallest fragments. 
The data also shows that the insert for A41 did not match to any of the seven E. coli 
genes 100 %. In fact, the A41 insert matched to each gene in the range of 32 %. For each 
gene match, the A41 insert usually produced 14 to 15 bp that matched to each gene. 
However, 78 % of the A41 insert matches to all seven genes. This fact suggests that the 
insert may not be directly part of any of the seven genes coding sequence, but a piece of 
DNA that contains 14-15 bp that match to each gene. If this is true, then the suggestion is 
that a 100 % direct sequence match is not necessary to produce GSE inhibition. Also, the 
JM109DE3 strain genomic sequence is not an exact match to the E coli strain (K12) that 
was used for comparison in this study. This fact implies that the A41 insert may not 
match totally in sequence because of the differences of genomic sequence between 
strains. 
The opportunity for further study exists in four principal areas. 1. Probe the library 
with a representative gene which would determine if the library was representative of the 
entire E. coli genome. 2. Northern Blots. Continued analysis of the A41 insert would 
involve doing Northern blotting of the total cellular RNA in JM109DE3 cells to 
determine which if any mRNA hybridize to a radio-labeled A41 antisense transcript. 
Transcripts that hybridize would be monitored in uninduced and induced cells for length 
and concentration differences indicative of premature transcriptional termination and 
degradation. A class lb mechanism would show lower levels or even absence of 
transcripts in IPTG induced cells compared to uninduced cells transcripts. A Class III 
mechanism would show shorter transcripts in induced cells compared to uninduced cells, 
and both the length and size of the transcript would help classify which of the seven 
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genes were being affected. 3. Re-sequence the A21 insert. Re-sequencing the A21 insert 
using purer DNA may help to determine the identity of the unknown bases that were 
incorporated within the insert. If the unknown bases can be determined, then the A21 
insert could match to E. coli genes better and significantly decrease the probability of 
chance. 4. Further screening of the GSE library. In this study, 850 colonies were 
screened and produced 2 possible GSEs that may suppress up to 27 different E. coli 
genes. The 850 colonies screened represent less than 1 % of the total colonies to be 
screened that constitute a representative library for an insert of 68 bp. Screening the 
remaining 99 % of the representative colonies has the potential to produce 500 to 1000 
separate GSEs. Some of these transcripts will undoubtedly harbor GSEs of various sizes 
that work via the antisense and/or dominant negative mutant mechanisms. The 
probability of finding a GSE that suppresses a gene with an unknown or putative function 
can only increase with further screening of the GSE library produced in this study. 
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